Alvaro Fernández-Pardo

Researcher
Haemostasis, Thrombosis, Arteriosclerosis and Vascular Biology Research Group, Medical Research Institute Hospital La Fe

Presentation(s):

• PB0728 - Bladder cancer patients have increased NETosis and impaired DNaseI-mediated NET degradation that can be therapeutically restored in vitro

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0731 - Neutrophil activation markers as novel biomarkers for advanced stages of high-grade serous ovarian cancer

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0744 - Coagulation markers improve the diagnosis of periprosthetic joint infection: involvement of immunothrombosis

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB1036 - The increase in plasma cell-free DNA in patients with venous thromboembolism is independent of DNaseI activity

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PB1143 - The Thrombin Generation Test represents a better tool than Factor VIII levels to assess the risk of bleedings in patients with hemophilia A

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM